Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Prevalence of clinically significant refractive error in children in Europe: Systematic review and meta-analysis

  • Megan Doyle ,

    Roles Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft

    ‡ MD and AOD are joint first authors to this work.

    Affiliation Centre for Eye Research Ireland, School of Physics, Clinical & Optometric Sciences, Technological University Dublin, Dublin, Ireland

  • Aoife O’Donnell ,

    Roles Data curation, Investigation, Methodology, Validation, Writing – review & editing

    ‡ MD and AOD are joint first authors to this work.

    Affiliation School of Medicine, Ulster University, Derry~Londonderry, Northern Ireland

  • Síofra Harrington,

    Roles Methodology, Supervision, Validation, Visualization, Writing – review & editing

    Affiliation Centre for Eye Research Ireland, School of Physics, Clinical & Optometric Sciences, Technological University Dublin, Dublin, Ireland

  • Veronica O’Dwyer,

    Roles Methodology, Supervision, Writing – review & editing

    Affiliation Centre for Eye Research Ireland, School of Physics, Clinical & Optometric Sciences, Technological University Dublin, Dublin, Ireland

  • Michael Moore

    Roles Conceptualization, Formal analysis, Methodology, Supervision, Validation, Visualization, Writing – review & editing

    michael.moore@tudublin.ie

    Affiliation Centre for Eye Research Ireland, School of Physics, Clinical & Optometric Sciences, Technological University Dublin, Dublin, Ireland

Abstract

Purpose

This meta-analysis estimated clinically significant refractive error prevalence in European children and examined variations based on cycloplegic versus non-cycloplegic refraction, age and sex.

Methods

A systematic review (PubMed, Cochrane Library, EMBASE, PROSPERO ID: CRD42022322608) identified studies (January 2000 – June 2024) reporting myopia (≤−0.50D), hyperopia (≥+2.00D) and astigmatism (≥1.00 DC) prevalence in children aged 4–17 years in Europe. Twenty-six studies from 14 countries (n = 37,282) were included. Pooled prevalence estimates (EPP) were calculated using a random-effects model with Freeman-Tukey double-arcsine transformation.

Results

Estimated pooled prevalences were refractive error: 17.90% (95% CI: 13.67–22.56), myopia: 14.31% (95% CI: 8.89–20.74; 24 studies), hyperopia: 10.20% (95% CI: 6.51–14.59; 11 studies), and astigmatism: 10.26% (95% CI: 5.83–15.74, eight studies). Cycloplegic and non-cycloplegic prevalence did not differ significantly (myopia: χ2 = 0.08, p = 0.78; hyperopia: χ2 = 0.29, p = 0.59). Myopia prevalence increased with age (6.17% at 4–9 years, 16.66% at 14 + years), while hyperopia declined (14.27% at 4–9 years, 7.04% at 10–13 years). Astigmatism remained stable; however, studies did not report its co-occurrence with myopia or hyperopia, limiting insights into its combined burden. No significant sex differences were observed. Data from 27 European countries were unavailable, limiting regional comparisons.

Conclusions

Approximately 18% of European children have clinically significant refractive error, with myopia increasing with age and hyperopia decreasing. Myopia prevalence was highest in Russia, hyperopia in Denmark, and astigmatism in Northern Ireland. Further studies reporting cycloplegic prevalences with improved geographical representation and more granular reporting – particularly of astigmatism and its co-occurrence with other refractive errors are needed for better comparability and management of refractive errors in European children.

Introduction

Uncorrected refractive error is a leading cause of visual impairment worldwide and a growing public health concern, particularly in children. Uncorrected refractive error not only limits educational and developmental potential but also increases the risk of amblyopia and, at higher magnitudes, irreversible sight-threatening complications such as myopic macular degeneration [1,2]. The global economic burden of visual impairment is substantial and far-reaching—estimated at $408.5 billion annually—with uncorrected refractive error contributing significantly [3].

While severe refractive error carries greater individual risk, the broader public health burden stems from the vast number of people with low to moderate levels of refractive error, particularly myopia. Despite predictions that nearly half the world’s population will be myopic by 2050 [4], robust data on paediatric refractive error in Europe remain surprisingly limited. Previous global reviews have included only a handful of European studies, often focusing exclusively on myopia or neglecting hyperopia and astigmatism altogether [5,6].

Understanding prevalence is not just a statistical exercise—it is essential for designing screening programmes, allocating resources, and preventing future visual impairment. Yet, inconsistent use of cycloplegia further complicates the comparability of findings. Cycloplegic refraction is the gold standard for epidemiological studies in children, critical for accurately identifying latent hyperopia and avoiding overestimating myopia [7,8]. However, its use is restricted in several European countries [9], raising concerns about methodological consistency across studies.

This review and meta-analysis aim to address these gaps by (1) providing updated estimates of the prevalence of clinically significant refractive error (myopia, hyperopia, and astigmatism) in European children aged 4–17 years, (2) comparing prevalence rates between cycloplegic and non-cycloplegic studies, and (3) analysing variations by age and sex.

Materials and methods

The current systematic review procedure adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA-P) guidelines and reported as per the meta-analyses of observational studies in epidemiology (MOOSE) checklist (S1 and S2 Tables, respectively). The review was registered on PROSPERO (University of York, https://www.crd.york.ac.uk/prospero/) (ID: CRD42022322608). Meta-analysis protocol is described in S1 Appendix.

Literature search strategy

Studies from European countries were extracted from PubMed, Cochrane Library and EMBASE databases. To maximise the available evidence, studies published from 1 January 2000–30 September 2024 were included. This broad timeframe was consistent with previous prevalence meta-analyses and ensured the inclusion of recent, methodologically robust studies while allowing adequate data coverage for European children, where studies remain limited [5,6,10]. Myopia prevalence and refractive error patterns have changed over the past two decades due to lifestyle shifts, increased near work, and reduced outdoor time [6]. Including studies from 2000 onward allows for the analysis of modern trends in paediatric refractive error prevalence. Two independent researchers (MD, AOD) performed the literature search following the same protocol between March 2022 and September 2024. The PubMed, Cochrane Library and EMBASE databases were searched using the search terms and Boolean operators for each country, as shown in Table 1.

thumbnail
Table 1. Search terms used for the Pubmed, Cochrane Library and EMBASE databases for each country in Europe.

https://doi.org/10.1371/journal.pone.0335666.t001

Studies were initially assessed for relevance based on their title and abstract. Accepted papers were collated into a list country-by-country for review. The World Health Organisation (WHO) region classification for European countries was used (https://www.who.int/countries) [11].

Study screening and appraisal

Articles reporting duplicate data were removed. Each study was scored out of 9 per the Joanna Briggs Institute (JBI) criteria (S3 Table). Any disagreements were settled by a third party (SH). The Grades of Recommendations Assessment, Development and Evaluation (GRADE) system was used to rate the quality of evidence of included studies. Observational studies were classified as low-quality evidence and could be further downgraded based on five criteria, following the procedure detailed in Balshem et al. [12]. Studies were then rated as having high, moderate, low, or very low-quality evidence. Excluded studies and the reasons for exclusion are in S5 Table. Data from each study were added to a prefabricated Microsoft Excel template, including authors, publication year, study location, urban or rural setting, sample size, sex distribution, age groups, refractive error definitions, cycloplegia use, and prevalence values. Fig 1 presents a flowchart of the paper selection process for systematic review following the literature search.

thumbnail
Fig 1. PRISMA flowchart of steps in identifying suitable studies.

https://doi.org/10.1371/journal.pone.0335666.g001

Inclusion and exclusion criteria

The inclusion criteria for the systematic review were:

  1. (1). Original research papers published between the years 2000–2024 (inclusive),
  2. (2). Studies were conducted in European countries,
  3. (3). Refractive error prevalence was reported in categories (myopia, hyperopia and astigmatism),
  4. (4). Definitions were provided for each refractive error category,
  5. (5). Participants in each study were between the ages of 4–17 inclusive,
  6. (6). Sample size must be stated,
  7. (7). Studies must have specified whether cycloplegic agents were employed,
  8. (8). Studies must be representative of the general paediatric population; thus, excluding those focusing on ocular or systemic disease states, or clinic-based studies,
  9. (9). Refractive error must not be self-reported; studies that used participant surveys to determine the prevalence of refractive error were excluded.

The literature search included studies from the following countries: Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia & Herzegovina, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Latvia, Lithuania, Luxembourg, Malta, Monaco, Montenegro, Netherlands, North Macedonia, Norway, Poland, Portugal, Republic of Moldova, Romania, Russian Federation, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom (and its components: England, Scotland, Wales and Northern Ireland (NI)).

Unpublished research and abstract-only data were not included due to the inability to assess study quality. Accessible studies written in a language other than English were translated online and assessed for eligibility.

Definitions

Refractive error prevalence pooled studies reporting myopia and hyperopia. Astigmatism was excluded from the refractive error prevalence analysis due to inadequate reporting and methodological limitations. Some studies reported separate prevalence values for myopia, hyperopia and astigmatism, but did not specify how many participants had both astigmatism and myopia or hyperopia. This lack of distinction could lead to double counting when calculating total clinically significant refractive error prevalence, as astigmatism often co-exists with myopia or hyperopia [13]. Instead, astigmatism prevalence was analysed separately. Clinically significant myopia was defined as spherical equivalent refraction (SER) ≤−0.50D, hyperopia as SER ≥+2.00D, and astigmatism as ≥1.00 DC. Myopia and hyperopia definitions followed the Refractive Error Study in Children (RESC) guidelines [14].

Within eligible studies, variations in hyperopia and astigmatism definitions resulted in the exclusion of some studies from specific refractive error analyses. For example, a study’s myopia prevalence data were included, but its hyperopia data were excluded if it did not use the ≥+2.00D required for inclusion. Subgroup analyses examined the effect of differing definitions on prevalence estimates. For hyperopia, studies which used the RESC definition (≥+2.00D) were compared to studies which used lower thresholds (+0.50 ≤ SER<+2.00D). Studies which defined astigmatism as ≥1.00 DC were compared to those which used a lower threshold of between 0.50 DC and <1.00DC.

Data analysis

Statistical analyses were performed with R version 4.1.2 (The R Project for Statistical Computing, r-project.org, 2021), an open-source statistical analysis software using the meta package. Individual study proportions and estimated pooled prevalences (EPP) were assessed and reported with 95% confidence intervals for each refractive error category. The Freeman-Tukey double arcsine transformation was applied to minimise the effect of studies with extremely high or low prevalence estimates on the overall pooled estimates. Cochran Q statistics and I2 were used to assess heterogeneity between studies. The random effects model was chosen to analyse pooled estimates to account for heterogeneity between studies. Leave-one-out analyses, Baujat plots and studentised residuals were used to identify potential outliers and quantify each study’s effect on the pooled proportion. Publication bias was evaluated using funnel plots and Egger’s test.

Subgroup analyses were performed to determine prevalence estimates by cycloplegic status, age, sex and refractive error definition. Prevalence values were compared between cycloplegic and non-cycloplegic studies (Table 2). Age was separated into three groups: 4–9 years, 10–13 years, and 14 + years.

thumbnail
Table 2. Summary characteristics of included studies (n = 37,282 participants). The participant count does not include O’Donoghue (2010) [15], O’Donoghue (2015) [20], or McCullough (2016) [17], as these papers all report on the Northern Ireland Childhood Errors of Refraction study, and the participant count for this dataset is taken from O’Donoghue (2011) [16].

https://doi.org/10.1371/journal.pone.0335666.t002

Results

Twenty-seven studies from 14 European countries were included in the principal analyses of myopia, hyperopia and astigmatism prevalence, with 37,282 participants. Table 2 presents the summary characteristics of the included studies. Five studies were conducted in Sweden, three each in Poland, the United Kingdom (England specifically), and Bulgaria, two each in the Netherlands, Northern Ireland (NI) and Denmark, and one each in Ireland, Greece, Bosnia & Herzegovina, Norway, Spain, Portugal, and Russia. Eighteen studies used cycloplegia, and nine did not. Twenty studies were school-based, and seven studies were population-based. Some studies were included more than once between the three refractive error analyses. Four papers from the Northern Ireland Childhood Errors of Refraction (NICER) study were included. Two reporting baseline data were in the principal analysis, while two reporting longitudinal data were only included in the age subgroup analyses. Two baseline prevalence papers from the NICER dataset were published: myopia and hyperopia [15], and astigmatism [16]. Their sample sizes were not double-counted in the current review. Only baseline NICER data were included in the principal prevalence analysis. Two additional studies reporting longitudinal myopia and hyperopia prevalence [17], and astigmatism prevalence [18], were included in the age subgroup analysis but excluded from the overall analysis due to their longitudinal nature. Additionally, one paper included participants from both Bulgaria and Greece [19]; the current review treats these as separate studies as they are independent datasets from different countries.

All included studies achieved a score of five or higher using the JBI Critical Appraisal tool, with the highest score being nine. Additional details on the JBI appraisal of included studies are presented in S3 Table. The quality of evidence was initially rated as “low” according to the GRADE Working Group protocol (S4 Table) due to the observational nature of the included studies [12]. The overall GRADE assessment classified the evidence as “very low” quality due to concerns about bias, including limited geographical coverage, underreporting of older age groups, less frequent reporting of hyperopia and astigmatism prevalence, and inconsistent refractive error definitions across studies.

Leave one out analysis did not identify any influential outliers (S1 Fig). There was insignificant asymmetry in the funnel plot, as confirmed by Egger’s test (z = −1.0148, p = 0.3102), indicating no publication bias (Fig 2).

thumbnail
Fig 2. Funnel plot of the included studies. Egger’s test did not indicate significant publication bias (z  = −1.0148, p = 0.3102).

https://doi.org/10.1371/journal.pone.0335666.g002

Refractive error prevalence

The EPP of significant refractive error (including myopia and hyperopia prevalence studies only) in children in Europe was 17.90% (95% CI: 13.67–22.56, I2 = 99.2%, Q = 5951.44 [df = 25], Fig 3). If studies reporting both myopia and hyperopia alongside astigmatism were included, the prevalence was 20.81% (95% CI: 15.27–26.97, I2 = 99.5%, Q = 7539.73 [df = 25]).

thumbnail
Fig 3. Forest plot displaying the prevalence of clinically significant refractive error in 4-17-year-olds in Europe across 27 studies (37,282 participants, 14 countries, 18 cycloplegic, 9 non-cycloplegic).

Refractive error prevalence was 17.90% (95% CI: 13.67–22.56).

https://doi.org/10.1371/journal.pone.0335666.g003

Myopia, hyperopia and astigmatism prevalences were 14.31% (95% CI: 8.89–20.74, I2 = 99.5%, Q = 4663.93 [df = 23]; 24 studies), 10.20% (95% CI: 6.51–14.59, I2 = 98.1%, Q = 528.22 [df = 10]; 11 studies) and 10.26% (95% CI: 5.83–15.74, I2 = 97.1%, Q = 239.45 [df = 7]; 8 studies) respectively (S2a-c Fig). Refractive error prevalence by country is depicted in Fig 4. Myopia was most prevalent in Russia (46.17%, 95% CI: 44.73–47.58), followed by Greece (37.24%, 95% CI: 33.40–41.20) and Spain (19.43%, 95% CI: 17.51–21.39), and with the Netherlands having the lowest prevalence (7.30%, 95% CI: 0.34–21.83; S3(a) Fig). Hyperopia was most prevalent in Denmark (27.64%, 95% CI: 23.61–31.92), followed by Northern Ireland (18.99%, 95% CI: 16.68–21.42) and Ireland (16.11%, 95% CI: 14.37–17.94), with Bosnia and Herzegovina having the lowest prevalence (4.01%, 95% CI: 2.82–5.27; S3(b) Fig). Astigmatism was most prevalent in Northern Ireland (21.46%, 95% CI: 19.03–24.00), followed by Ireland (17.40%, 95% CI: 15.60–19.29) and Greece (17.18%, 95% CI: 14.23–20.34) with Denmark having the lowest prevalence (4.27%, 95% CI: 2.57–6.37; S3(c) Fig).

thumbnail
Fig 4. Heat map of clinically significant paediatric refractive error prevalence ((myopia ≤ −0.50 and hyperopia ≤+2.00D) by country.

The EPP of clinically significant refractive error was 17.90% (95% CI: 13.67–22.56). Refractive error prevalence was highest in Russia (46.17%, 95% CI: 44.74–47.59), followed by Greece (37.24%, 95% CI: 33.37–41.19) and Northern Ireland (31.15%, 95% CI: 28.39–33.98)). Notably, only myopia prevalence was included from Russia and Greece, and there was a lack of clinically significant hyperopia or astigmatism data. Mapping data from http://www.naturalearthdata.com/.

https://doi.org/10.1371/journal.pone.0335666.g004

Cycloplegic versus non-cycloplegic prevalence

The EPP of clinically significant refractive error in children in Europe was 19.17% (95% CI: 11.79–27.84; 17 studies) in cycloplegic studies and 15.50% (6.80–26.91; nine studies) in non-cycloplegic studies (χ2 = 0.30, p = 0.58). The EPP of myopia was 13.68% (95% CI: 7.18–21.83; 16 studies) in cycloplegic studies and 15.58% (95% CI: 6.32–27.95; seven studies) in non-cycloplegic studies (χ2 = 0.08, p = 0.78; Fig 5a). The EPP of hyperopia was 10.74% (95% CI: 6.52–15.85; nine studies) in cycloplegic studies and 7.96% (95% CI: 1.60–18.47; two studies) in non-cycloplegic studies (χ2 = 0.29, p = 0.59; Fig 5b). The EPP of astigmatism was 9.32% (95% CI: 4.28–15.99; 7 studies) in cycloplegic studies. Only one non-cycloplegic study reported astigmatism prevalence according to the definition for the current review, limiting EPP calculation (13.25%, 95% CI: 3.84–27.08).

thumbnail
Fig 5. Forest plot of the prevalence of clinically significant (a) myopia and (b) hyperopia in cycloplegic and non-cycloplegic studies.

Myopia prevalence in cycloplegic studies was 13.68% (95% CI: 7.18–21.83) and 15.58% (95% CI: 6.32–27.95) in non-cycloplegic studies. There was no significant difference in myopia prevalence rates between cycloplegic and non-cycloplegic studies (χ2 = 0.08, p = 0.78). Hyperopia prevalence in cycloplegic studies was 10.74% (95% CI: 6.52–15.85) and 7.96% (95% CI: 1.60–18.47) in non-cycloplegic studies. There was no significant difference in hyperopia prevalence rates between cycloplegic and non-cycloplegic studies (χ2 = 0.29, p = 0.59).

https://doi.org/10.1371/journal.pone.0335666.g005

Age

Refractive error prevalence was lowest in the 4–9 year age group (14.31%, 95% CI: 8.75–20.93), increasing to its maximum in the 10–13 year group (19.14%, 95% CI: 12.55–26.71) and slightly decreasing in the 14 + year group (16.65%, 95% CI: 6.72–29.78). Myopia prevalence increased with age, more than doubling from 6.17% (95% CI: 2.61–11.03) in 4–9-year-olds to 16.42% (95% CI: 10.88–22.82) in 10–13-year-olds (χ2 = 8.53, p = 0.014), before stabilising in the 14 + age group (16.66%, 95% CI: 7.28–28.84). Hyperopia prevalence reduced with age from 14.27% (95% CI: 8.67–20.96) in 4–9-year-olds to 7.04% (95% CI: 2.34–13.82) in 10–13-year-olds (χ2 = 2.53, p = 0.112). No studies reported hyperopia prevalence in the 14 + year age group. Astigmatism prevalence remained stable between the 4–9 year (12.96%, 95% CI: 6.13–21.83) and 10–13 year (11.84%, 95% CI: 6.23–18.87) age groups, and was not significantly different at 14 + years (17.48%, 95% CI: 14.03–21.23; χ2 = 0.37, p = 0.83). Only one study reported astigmatism prevalence in the 14 + year age group [18].

Sex

There was no significant difference in refractive error prevalence between females (14.88%, 95% CI: 8.98–21.94) and males (14.02%, 95% CI: 8.28–20.95, χ2 = 0.03, p = 0.85). Similarly, myopia prevalence (females: 15.67%, 95% CI: 8.71–24.18; males: 14.65%, 95% CI: 7.91–22.99, χ² = 0.03, p = 0.86) and hyperopia prevalence did not differ significantly by sex (females: 4.92%, 95% CI: 4.13–5.77; males: 5.17%, 95% CI: 4.38–6.03, χ² = 0.18, p = 0.67). Astigmatism prevalence by sex was only reported in one study, which defined astigmatism as >0.25DC. Including this study could artificially inflate prevalence, as such low levels of astigmatism are not clinically significant.

Refractive error definition

Eight of the included studies provided hyperopia prevalence values using a definition lower than ≥+2.00D. A subgroup analysis showed that lower definitions of hyperopia (+0.50D ≤ SER<+2.00D) result in higher prevalence (28.47%, 95% CI: 20.46–37.22, χ2 = 14.47, p < 0.01) than studies using a hyperopia definition of ≥+2.00D as reported above.

Astigmatism prevalence was higher in studies with lower definitions (between 0.50 DC and <1.00DC,16.29%, 95% CI: 8.87–25.41) compared to ≥1.00 DC (10.27%, 95% CI: 5.96–15.56). However, no statistically significant difference in prevalence values was found (χ2 = 1.62, p = 0.20).

Discussion

This review of European studies found the prevalence of clinically significant refractive error to be 17.90%, with myopia (≤ –0.50 D), hyperopia (≥ + 2.00 D), and astigmatism (≥ 1.00 DC) present in 14.31%, 10.20%, and 10.26% of participants, respectively. Prevalence estimates from cycloplegic studies were lower for myopia and higher for hyperopia than non-cycloplegic studies, although these differences were not statistically significant. Myopia prevalence increased with age, while hyperopia decreased, and astigmatism remained relatively stable. No significant differences in myopia or hyperopia prevalence were observed between males and females. Importantly, variation in the definition of hyperopia across studies substantially influenced reported prevalence rates.

Clinically significant refractive error prevalence

Nearly one in five children in Europe (17.90%) had clinically significant refractive error. Most previous reviews reported separate figures for myopia and hyperopia, rather than overall refractive error prevalence. This review followed that approach, which likely underestimates true prevalence by excluding astigmatism. Including studies that reported astigmatism raised the estimate to 20.81%. However, due to limited data on how astigmatism co-exists and overlaps with myopia and hyperopia, it couldn’t be included in the primary analysis without risking double-counting. Only five countries (Ireland, Northern Ireland, Denmark, Sweden, and Bulgaria) reported data on all three conditions. While all included countries had myopia data, fewer had data on hyperopia (n = 8) and astigmatism (n = 6). This highlights a clear gap: Europe urgently needs more consistent, comprehensive data on childhood refractive error.

Myopia prevalence

Liang et al.’s review reported a higher European paediatric myopia prevalence of 22.60% (95% CI: 17.49–27.72) compared to 14.31% in the present study [10]. However, their estimate included two older studies (1990–2000) with exceptionally high prevalence (EPP: 44.16%) and several others excluded from the present review due to issues such as duplicate data, mismatched age ranges, focus on vision screening failures (which may underestimate true prevalence due to conservative VA thresholds), and unclear cycloplegia use (see S5 Table). These methodological differences likely account for the discrepancy.

A 2021 systematic review of 41 studies from China, Hong Kong, Macau, and Taiwan reported a higher myopia prevalence of 38.0% (95% CI: 35.1–41.1) and lower hyperopia prevalence of 5.2% (95% CI: 3.1–8.6) than observed in European children in the present review [44]. These differences likely reflect ethnic and environmental influences. Myopia is strongly associated with intensive education, prolonged near work, limited outdoor time, and urban living [20,4547]. Given earlier academic demands and higher urban density in many parts of Asia, elevated myopia rates are expected [4851].

Globally, Hashemi et al. reported a pooled childhood myopia prevalence of 11.7% based on cycloplegic data from 49 studies (n = 606,155), but their European sample included only studies published between 2000 and 2009 [6]. As prevalence tends to rise in more recent cohorts, this likely contributes to the lower estimate compared with the present review, which includes studies up to June 2024.

Hyperopia prevalence

Hashemi et al. estimated a global pooled prevalence of childhood hyperopia (≥ + 2.00 D) at 4.6% (95% CI: 3.9–5.2), based on 45 studies involving 200,995 children [6]. Prevalence varied regionally, from 2.2% in Southeast Asia to 14.3% in the Americas. The European estimate was 9.0% (95% CI: 4.3–13.7), drawn from just seven studies in Turkey, Poland, the Netherlands, and Sweden. In contrast, the current review includes additional data from countries such as Denmark (27.64%) [35] and Northern Ireland (18.99%) [15], contributing to a higher pooled European estimate of 10.20%. While Castagno et al. reported hyperopia prevalence ranging from 2.1% to 19.3% across 40 studies in children aged 5–15, they did not provide Europe-specific figures [5]. By incorporating a broader and more recent range of studies, this review offers a more comprehensive estimate of childhood hyperopia prevalence in Europe.

Astigmatism prevalence

The present review found a prevalence of 10.26% (95% CI: 5.83–15.74) among European children, with the highest rates in Northern Ireland (24% in 6–7-year-olds) and Ireland (19%) [16,36]. In contrast, Hashemi et al. reported a global childhood astigmatism prevalence of 14.9% (95% CI: 12.7–17.1) [6], based on 48 studies and 152,570 participants, using a lower (>0.50 DC) threshold.

Astigmatism may fluctuate over time, with children crossing clinical thresholds during follow-up [20]. Prevalence has also been associated with ethnicity, refractive error type, and educational level [52]. However, only two studies in this review provided data distinguishing myopic from hyperopic astigmatism, limiting further analysis.

Cycloplegic vs non-cycloplegic comparisons

This meta-analysis found slightly lower myopia prevalence (13.68% vs. 15.58%) and higher hyperopia prevalence (10.74% vs. 7.96%) in cycloplegic compared to non-cycloplegic studies, though differences were not statistically significant. However, no included study assessed both methods within the same population, limiting direct comparison and introducing potential bias from differences in study design, demographics, and methodology. Only two non-cycloplegic studies reported hyperopia prevalence, further restricting comparison.

Nonetheless, external studies consistently demonstrate the importance of cycloplegia. Sankaridurg et al. showed that non-cycloplegic refraction in over 6,000 children in Shanghai significantly overestimated myopia and underestimated hyperopia [53]. Similar findings have been reported elsewhere [5456], reinforcing the need for cycloplegic assessment in paediatric populations.

In many European countries, however, optometrists are restricted from using diagnostic drops [9], posing a barrier to standardised, cycloplegia-based studies. A multidisciplinary approach may help overcome this challenge and improve the accuracy of epidemiological data.

Age and sex

The findings of this review align with previous research showing a clear age-related shift in refractive error: hyperopia declines while myopia increases throughout childhood [5,17,57]. In the longitudinal NICER study, myopia prevalence rose from 1.9% to 14.6% in children aged 6–7–12–13, and from 16.4% to 18.6% between ages 12–13 and 18–20. Over the same period, hyperopia in the younger cohort declined from 21.7% to 14.2% [17]. Similarly, Castagno et al. reported a steady drop in hyperopia (≥+2.00D) [5], from 8.4% at age six to around 1% by age 15—consistent with the natural emmetropisation process.

Astigmatism follows a different developmental course. It is high at birth, typically decreases as the cornea flattens, and stabilises by around age four [58,59]. In this review, astigmatism prevalence remained relatively stable (~10%) from ages 4–13, suggesting minimal change beyond early childhood.

Only five studies assessed refractive error in children aged 14 and above, and most focused on myopia and astigmatism. More research is needed in this age group to understand adolescent refractive development and inform future eye care planning and public health policy [60,61].

Sex-based trends remain unclear. While some studies report higher myopia prevalence or progression in females [10,62], others find no difference [63,64]. This review found no significant sex-based differences, but only 12 studies reported sex-disaggregated data. Standardised reporting by sex is needed to enable more robust analyses and guide equitable care strategies.

Improving generalisability and clarity in prevalence reporting

This review identified no eligible prevalence studies from 27 European countries. Using the UN Geoscheme [65], Northern Europe had the highest representation (13 studies across six countries), while Western Europe was least represented, with only the Netherlands included. This lack of data prevented meaningful regional subgroup analysis, as single-country data cannot reflect broader regional trends. More studies from under-represented areas are needed to improve geographic balance and generalisability in future meta-analyses.

Clinically significant hyperopia was defined as ≥+2.00D. Nine studies using lower thresholds were excluded to avoid overestimating prevalence by including children with age-appropriate hyperopic reserve. While measuring hyperopic reserve is valuable—especially due to its protective role against myopia [66,67], lower thresholds hinder comparability across studies. Standardised definitions are essential for consistent epidemiological reporting [14].

Most studies used spherical equivalent refraction (SER), which may misclassify children with high astigmatism. This can skew prevalence estimates, underestimating hyperopia and overestimating myopia. Alternative methods, such as least myopic meridian or vector analysis, may offer more accurate classification [2,68].

Strengths, limitations and future directions

This systematic review and meta-analysis, conducted in line with PRISMA guidelines, provides the first comprehensive estimate of childhood refractive error prevalence across Europe. A key strength is identifying critical data gaps—specifically, the absence of eligible studies in 27 European countries. Rather than a limitation, this highlights urgent research needs in under-represented regions. Inconsistencies in study protocols and refractive error definitions also posed challenges, reinforcing the importance of standardisation in future research.

The broad timeframe and heterogeneous cohorts may have influenced the pooled estimates. This is an inherent feature of prevalence meta-analyses, and the use of a random-effects model with sensitivity analyses was intended to account for this [6971].

This review presents the first comparative analysis of cycloplegic versus non-cycloplegic prevalence estimates. While direct within-study comparisons were unavailable, the findings offer important insights into the influence of cycloplegia on prevalence data. Subgroup analyses by age and sex further strengthen the review, although the age-based findings are drawn mainly from cross-sectional data. With only one longitudinal dataset (NICER) included, future meta-analyses incorporating longitudinal data could offer a clearer picture of refractive error progression and its determinants [72]. Future studies should standardise methods and expand coverage to under-represented regions, enabling more accurate and comparable prevalence estimates.

Conclusions

This meta-analysis provides the first comprehensive estimates of clinically significant refractive error among European children, with an overall prevalence of 17.9%, including 14.3% for myopia, 10.2% for hyperopia, and 10.3% for astigmatism. It also demonstrates the impact of cycloplegia on prevalence estimates and highlights critical data gaps across much of Europe.

To ensure accurate, comparable, and actionable data, there is an urgent need for globally coordinated efforts to standardise study protocols, definitions, and reporting. Myopia, hyperopia, and astigmatism each carry distinct clinical and public health implications. Consistent, granular data will enable more targeted screening, optimised resource allocation, and more effective eye care strategies in Europe and worldwide.

Supporting information

S1 Fig. Leave-one-out sensitivity plot of all studies reporting myopia or hyperopia prevalence in Europe.

Leave-one-out analyses were performed to determine how much individual studies affect the pooled estimates of the other studies.

https://doi.org/10.1371/journal.pone.0335666.s002

(TIF)

S2 Fig. Forest plots displaying the prevalence of clinically significant (a) myopia (≤−0.50D), (b) hyperopia (≥+2.00D) and (c) astigmatism (≥1.00 DC) in 4–17-year-olds in Europe across 27 studies (37,282 participants, 14 countries, 18 cycloplegic, 9 non-cycloplegic).

Myopia prevalence was 14.31% (95% CI: 8.89–20.74). Hyperopia prevalence was 10.20% (95% CI: 6.51–14.59). Astigmatism prevalence was 10.26% (95% CI: 5.83–15.74).

https://doi.org/10.1371/journal.pone.0335666.s003

(TIF)

S3 Fig. Heat maps of clinically significant paediatric refractive error prevalence by country.

Figure 3(a) depicts myopia (≤−0.50D) prevalence, (b) hyperopia (≤+2.00D) prevalence and (c) astigmatism (≥1.00 DC) prevalence. Mapping data from http://www.naturalearthdata.com/.

https://doi.org/10.1371/journal.pone.0335666.s004

(TIF)

S1 Table. PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) 2015 checklist: recommended items to address in a systematic review protocol.

https://doi.org/10.1371/journal.pone.0335666.s005

(DOCX)

S2 Table. MOOSE (Meta-analyses Of Observational Studies in Epidemiology) checklist.

https://doi.org/10.1371/journal.pone.0335666.s006

(PDF)

S3 Table. Critical appraisal of included papers using the Joanna Briggs Institute tool.

https://doi.org/10.1371/journal.pone.0335666.s007

(DOCX)

S4 Table. Grading of Recommendations, Assessment, Development and Evaluation (GRADE) summary of findings.

https://doi.org/10.1371/journal.pone.0335666.s008

(DOCX)

S5 Table. Excluded papers and reason for exclusion.

https://doi.org/10.1371/journal.pone.0335666.s009

(DOCX)

References

  1. 1. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96(5):614–8. pmid:22133988
  2. 2. Flitcroft DI, He M, Jonas JB, Jong M, Naidoo K, Ohno-Matsui K, et al. IMI - Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies. Invest Ophthalmol Vis Sci. 2019;60(3):M20–30. pmid:30817826
  3. 3. Marques AP, Ramke J, Cairns J, Butt T, Zhang JH, Muirhead D, et al. Global economic productivity losses from vision impairment and blindness. EClinicalMedicine. 2021;35:100852. pmid:33997744
  4. 4. Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036–42. pmid:26875007
  5. 5. Castagno VD, Fassa AG, Carret MLV, Vilela MAP, Meucci RD. Hyperopia: a meta-analysis of prevalence and a review of associated factors among school-aged children. BMC Ophthalmol. 2014;14:163. pmid:25539893
  6. 6. Hashemi H, Fotouhi A, Yekta A, Pakzad R, Ostadimoghaddam H, Khabazkhoob M. Global and regional estimates of prevalence of refractive errors: Systematic review and meta-analysis. J Curr Ophthalmol. 2017;30(1):3–22. pmid:29564404
  7. 7. Morgan IG, Iribarren R, Fotouhi A, Grzybowski A. Cycloplegic refraction is the gold standard for epidemiological studies. Acta Ophthalmol. 2015;93(6):581–5. pmid:25597549
  8. 8. Yasin N, Farooq S, Sharjeel M, Shahzad MA, Khalil I, Ahmed M. Diagnosis and treatment of accommodative spasm with cycloplegics. PJMHS. 2022;16(1):888–90.
  9. 9. ECOO. European Council of Optometry and Optics Blue Book 2020. 2020. Available from: https://ecoo.info/wp-content/uploads/2022/02/ECOO_BlueBook_2020-compressed_png.pdf
  10. 10. Liang J, Pu Y, Chen J, Liu M, Ouyang B, Jin Z, et al. Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis. Br J Ophthalmol. 2025;109(3):362–71. pmid:39317432
  11. 11. World Health Organization (WHO). Countries. 2023. Available from: https://www.who.int/countries
  12. 12. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–6. pmid:21208779
  13. 13. Huang J, Maguire MG, Ciner E, Kulp MT, Cyert LA, Quinn GE, et al. Risk factors for astigmatism in the vision in preschoolers study. Optom Vis Sci. 2014;91(5):514–21. pmid:24727825
  14. 14. Negrel AD, Maul E, Pokharel GP, Zhao J, Ellwein LB. Refractive error study in children: sampling and measurement methods for a multi-country survey. Am J Ophthalmol. 2000;129(4):421–6. pmid:10764848
  15. 15. O’Donoghue L, McClelland JF, Logan NS, Rudnicka AR, Owen CG, Saunders KJ. Refractive error and visual impairment in school children in Northern Ireland. Br J Ophthalmol. 2010;94(9):1155–9. pmid:20494909
  16. 16. O’Donoghue L, Rudnicka AR, McClelland JF, Logan NS, Owen CG, Saunders KJ. Refractive and corneal astigmatism in white school children in northern ireland. Invest Ophthalmol Vis Sci. 2011;52(7):4048–53. pmid:21372019
  17. 17. McCullough SJ, O’Donoghue L, Saunders KJ. Six year refractive change among white children and young adults: evidence for significant increase in myopia among white UK children. PLoS One. 2016;11(1):e0146332. pmid:26783753
  18. 18. O’Donoghue L, Breslin KM, Saunders KJ. The Changing Profile of Astigmatism in Childhood: The NICER Study. Invest Ophthalmol Vis Sci. 2015;56(5):2917–25. pmid:26024077
  19. 19. Plainis S, Moschandreas J, Nikolitsa P, Plevridi E, Giannakopoulou T, Vitanova V, et al. Myopia and visual acuity impairment: a comparative study of Greek and Bulgarian school children. Ophthalmic Physiol Opt. 2009;29(3):312–20. pmid:19422563
  20. 20. O’Donoghue L, Kapetanankis VV, McClelland JF, Logan NS, Owen CG, Saunders KJ, et al. Risk factors for childhood myopia: findings from the NICER study. Invest Ophthalmol Vis Sci. 2015;56(3):1524–30. pmid:25655799
  21. 21. Villarreal MG, Ohlsson J, Abrahamsson M, Sjöstrom A, Sjöstrand J. Myopisation: the refractive tendency in teenagers. Prevalence of myopia among young teenagers in Sweden. Acta Ophthalmol Scand. 2000;78(2):177–81. pmid:10794252
  22. 22. Grönlund MA, Andersson S, Aring E, Hård A-L, Hellström A. Ophthalmological findings in a sample of Swedish children aged 4-15 years. Acta Ophthalmol Scand. 2006;84(2):169–76. pmid:16637831
  23. 23. Czepita D, Zejmo M, Mojsa A. Prevalence of myopia and hyperopia in a population of Polish schoolchildren. Ophthalmic Physiol Opt. 2007;27(1):60–5. pmid:17239191
  24. 24. Hendricks TJW, DE Brabander J, van Der Horst FG, Hendrikse F, Knottnerus JA. Relationship between habitual refractive errors and headache complaints in schoolchildren. Optom Vis Sci. 2007;84(2):137–43. pmid:17299344
  25. 25. Abdi S, Lennerstrand G, Pansell T, Rydberg A. Orthoptic findings and asthenopia in a population of Swedish schoolchildren aged 6 to 16 years. Strabismus. 2008;16(2):47–55. pmid:18484506
  26. 26. Williams C, Northstone K, Howard M, Harvey I, Harrad RA, Sparrow JM. Prevalence and risk factors for common vision problems in children: data from the ALSPAC study. Br J Ophthalmol. 2008;92(7):959–64. pmid:18480306
  27. 27. Rudnicka AR, Owen CG, Nightingale CM, Cook DG, Whincup PH. Ethnic differences in the prevalence of myopia and ocular biometry in 10- and 11-year-old children: the Child Heart and Health Study in England (CHASE). Invest Ophthalmol Vis Sci. 2010;51(12):6270–6. pmid:20631242
  28. 28. Logan NS, Shah P, Rudnicka AR, Gilmartin B, Owen CG. Childhood ethnic differences in ametropia and ocular biometry: the Aston Eye Study. Ophthalmic Physiol Opt. 2011;31(5):550–8. pmid:21762431
  29. 29. Polling J-R, Loudon SE, Klaver CCW. Prevalence of amblyopia and refractive errors in an unscreened population of children. Optom Vis Sci. 2012;89(11):e44-9. pmid:23069721
  30. 30. Larsson E, Holmström G, Rydberg A. Ophthalmological findings in 10-year-old full-term children--a population-based study. Acta Ophthalmol. 2015;93(2):192–8. pmid:25041696
  31. 31. Lundberg K, Suhr Thykjaer A, Søgaard Hansen R, Vestergaard AH, Jacobsen N, Goldschmidt E, et al. Physical activity and myopia in Danish children-The CHAMPS Eye Study. Acta Ophthalmol. 2018;96(2):134–41. pmid:28671340
  32. 32. Tideman JWL, Polling JR, Hofman A, Jaddoe VW, Mackenbach JP, Klaver CC. Environmental factors explain socioeconomic prevalence differences in myopia in 6-year-old children. Br J Ophthalmol. 2018;102(2):243–7. pmid:28607175
  33. 33. Popović-Beganović A, Zvorničanin J, Vrbljanac V, Zvorničanin E. The Prevalence of Refractive Errors and Visual Impairment among School Children in Brčko District, Bosnia and Herzegovina. Semin Ophthalmol. 2018;33(7–8):858–68. pmid:30365355
  34. 34. Hagen LA, Gjelle JVB, Arnegard S, Pedersen HR, Gilson SJ, Baraas RC. Prevalence and possible factors of myopia in norwegian adolescents. Sci Rep. 2018;8(1):13479. pmid:30194363
  35. 35. Sandfeld L, Weihrauch H, Tubaek G, Mortzos P. Ophthalmological data on 4.5- to 7-year-old Danish children. Acta Ophthalmol. 2018;96(4):379–83. pmid:29369530
  36. 36. Harrington SC, Stack J, Saunders K, O’Dwyer V. Refractive error and visual impairment in Ireland schoolchildren. Br J Ophthalmol. 2019;103(8):1112–8. pmid:30315130
  37. 37. Slaveykov K, Trifonova K. Refraction in Preschool Children in Kazanlak, Bulgaria. Folia Med (Plovdiv). 2020;62(2):345–51. pmid:32666755
  38. 38. Demir P, Baskaran K, Theagarayan B, Gierow P, Sankaridurg P, Macedo AF. Refractive error, axial length, environmental and hereditary factors associated with myopia in Swedish children. Clin Exp Optom. 2021;104(5):595–601. pmid:33689658
  39. 39. Alvarez-Peregrina C, Martinez-Perez C, Villa-Collar C, González-Pérez M, González-Abad A, Sánchez-Tena MÁ, et al. The Prevalence of Myopia in Children in Spain: An Updated Study in 2020. Int J Environ Res Public Health. 2021;18(23):12375. pmid:34886101
  40. 40. Dragomirova M, Antonova A, Stoykova S, Mihova G, Grigorova D. Myopia in Bulgarian school children: prevalence, risk factors, and health care coverage. BMC Ophthalmol. 2022;22(1):248. pmid:35658918
  41. 41. Martinez-Perez C, Alvarez-Peregrina C, Brito R, Sánchez-Tena MÁ, Grupo de Investigação Optovisão Isec Lisboa. The Evolution and the Impact of Refractive Errors on Academic Performance: A Pilot Study of Portuguese School-Aged Children. Children (Basel). 2022;9(6):840. pmid:35740777
  42. 42. Monika M, Durajczyk M. Evaluation of the Prevalence of Refractive Defects and Ocular Function in a Group of 1518 Children Aged 8 Years in Northwestern Poland-A Retrospective Study. J Clin Med. 2023;12(8):2880. pmid:37109217
  43. 43. Bikbov MM, Kazakbaeva GM, Fakhretdinova AA, Tuliakova AM, Iakupova EM, Panda-Jonas S, et al. Prevalence and associated factors of myopia in children and adolescents in Russia: the Ural Children Eye Study. Br J Ophthalmol. 2024;108(4):593–8. pmid:37019624
  44. 44. Tang Y, Chen A, Zou M, Liu Z, Young CA, Zheng D, et al. Prevalence and time trends of refractive error in Chinese children: A systematic review and meta-analysis. J Glob Health. 2021;11:08006. pmid:34327000
  45. 45. Sun JT, An M, Yan XB, Li GH, Wang DB. Prevalence and Related Factors for Myopia in School-Aged Children in Qingdao. J Ophthalmol. 2018;2018:9781987. pmid:29507811
  46. 46. Harrington SC, O’Dwyer V. Ocular biometry, refraction and time spent outdoors during daylight in Irish schoolchildren. Clin Exp Optom. 2020;103(2):167–76. pmid:31187504
  47. 47. Wang Y, Liu L, Lu Z, Qu Y, Ren X, Wang J, et al. Rural-urban differences in prevalence of and risk factors for refractive errors among school children and adolescents aged 6-18 years in Dalian, China. Front Public Health. 2022;10:917781. pmid:36106164
  48. 48. Rose KA, Morgan IG, Smith W, Burlutsky G, Mitchell P, Saw S-M. Myopia, lifestyle, and schooling in students of Chinese ethnicity in Singapore and Sydney. Arch Ophthalmol. 2008;126(4):527–30. pmid:18413523
  49. 49. Mountjoy E, Davies NM, Plotnikov D, Smith GD, Rodriguez S, Williams CE, et al. Education and myopia: assessing the direction of causality by mendelian randomisation. BMJ. 2018;361:k2022. pmid:29875094
  50. 50. Pan C-W, Wu R-K, Li J, Zhong H. Low prevalence of myopia among school children in rural China. BMC Ophthalmol. 2018;18(1):140. pmid:29890943
  51. 51. United Nations Department of Economic and Social Affairs. World Urbanization Prospects. 2018. https://population.un.org/wup/Publications/Files/WUP2018-Report.pdf
  52. 52. Zhang J, Wu Y, Sharma B, Gupta R, Jawla S, Bullimore MA. Epidemiology and burden of astigmatism: a systematic literature review. Optom Vis Sci. 2023;100(3):218–31. pmid:36749017
  53. 53. Sankaridurg P, He X, Naduvilath T, Lv M, Ho A, Smith E 3rd, et al. Comparison of noncycloplegic and cycloplegic autorefraction in categorizing refractive error data in children. Acta Ophthalmol. 2017;95(7):e633–40. pmid:29110438
  54. 54. Hu YY, Wu JF, Lu TL, Wu H, Sun W, Wang XR, et al. Effect of cycloplegia on the refractive status of children: the Shandong children eye study. PLoS One. 2015;10(2):e0117482. pmid:25658329
  55. 55. Sun Y-Y, Wei S-F, Li S-M, Hu J-P, Yang X-H, Cao K, et al. Cycloplegic refraction by 1% cyclopentolate in young adults: is it the gold standard? The Anyang University Students Eye Study (AUSES). Br J Ophthalmol. 2018;:bjophthalmol-2018-312199. pmid:29930099
  56. 56. Sanfilippo PG, Chu B-S, Bigault O, Kearns LS, Boon M-Y, Young TL, et al. What is the appropriate age cut-off for cycloplegia in refraction?. Acta Ophthalmol. 2014;92(6):e458-62. pmid:24641244
  57. 57. Wu JF, Bi HS, Wang SM, Hu YY, Wu H, Sun W, et al. Refractive error, visual acuity and causes of vision loss in children in Shandong, China. The Shandong Children Eye Study. PLoS One. 2013;8(12):e82763. pmid:24376575
  58. 58. Gwiazda J, Scheiman M, Mohindra I, Held R. Astigmatism in children: changes in axis and amount from birth to six years. Invest Ophthalmol Vis Sci. 1984;25(1):88–92. pmid:6698734
  59. 59. Read SA, Collins MJ, Carney LG. A review of astigmatism and its possible genesis. Clin Exp Optom. 2007;90(1):5–19. pmid:17177660
  60. 60. Cao H, Cao X, Cao Z, Zhang L, Han Y, Guo C. The prevalence and causes of pediatric uncorrected refractive error: Pooled data from population studies for Global Burden of Disease (GBD) sub-regions. PLoS One. 2022;17(7):e0268800. pmid:35776717
  61. 61. Naidoo KS, Jaggernath J. Uncorrected refractive errors. Indian J Ophthalmol. 2012;60(5):432–7. pmid:22944755
  62. 62. Li S-M, Ren M-Y, Gan J, Zhang S-G, Kang M-T, Li H, et al. Machine Learning to Determine Risk Factors for Myopia Progression in Primary School Children: The Anyang Childhood Eye Study. Ophthalmol Ther. 2022;11(2):573–85. pmid:35061239
  63. 63. Harrington SC, Stack J, O’Dwyer V. Risk factors associated with myopia in schoolchildren in Ireland. Br J Ophthalmol. 2019;103(12):1803–9. pmid:30745305
  64. 64. Theophanous C, Modjtahedi BS, Batech M, Marlin DS, Luong TQ, Fong DS. Myopia prevalence and risk factors in children. Clin Ophthalmol. 2018;12:1581–7. pmid:30214142
  65. 65. UN Statistics Division. Standard country or area codes for statistical use (M49). United Nations Statistics Division Methodology. https://unstats.un.org/unsd/methodology/m49/. 2025. Accessed 2025 May 2.
  66. 66. Morgan IG, Rose KA, Ellwein LB, Refractive Error Study in Children Survey Group. Is emmetropia the natural endpoint for human refractive development? An analysis of population-based data from the refractive error study in children (RESC). Acta Ophthalmol. 2010;88(8):877–84. pmid:19958289
  67. 67. Rozema J, Dankert S, Iribarren R. Emmetropization and nonmyopic eye growth. Surv Ophthalmol. 2023;68(4):759–83. pmid:36796457
  68. 68. Longwill S, Moore M, Flitcroft DI, Loughman J. Using electronic medical record data to establish and monitor the distribution of refractive errors. J Optom. 2022;15 Suppl 1(Suppl 1):S32–42. pmid:36220741
  69. 69. Migliavaca CB, Stein C, Colpani V, Barker TH, Ziegelmann PK, Munn Z, et al. Meta-analysis of prevalence: I2 statistic and how to deal with heterogeneity. Res Synth Methods. 2022;13(3):363–7. pmid:35088937
  70. 70. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Random-Effects Model. In: Introduction to Meta-Analysis. Wiley;2009:69–75.
  71. 71. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974–8. pmid:23963506
  72. 72. Olson TL, Roggman LA, Innocenti MS. Developmental research methods with infants & young children. In: Benson JB, editor. Encyclopedia of infant and early childhood development. Elsevier. 2020. p. 456–68.